Literature DB >> 33615327

Transporting Subgroup Analyses of Randomized Controlled Trials for Planning Implementation of New Interventions.

Megha L Mehrotra, Daniel Westreich, M Maria Glymour, Elvin Geng, David V Glidden.   

Abstract

Subgroup analyses of randomized controlled trials guide resource allocation and implementation of new interventions by identifying groups of individuals who are likely to benefit most from the intervention. Unfortunately, trial populations are rarely representative of the target populations of public health or clinical interest. Unless the relevant differences between trial and target populations are accounted for, subgroup results from trials might not reflect which groups in the target population will benefit most from the intervention. Transportability provides a rigorous framework for applying results derived in potentially highly selected study populations to external target populations. The method requires that researchers measure and adjust for all variables that 1) modify the effect of interest and 2) differ between the target and trial populations. To date, applications of transportability have focused on the external validity of overall study results and understanding within-trial heterogeneity; however, this approach has not yet been used for subgroup analyses of trials. Through an example from the Iniciativa Profilaxis Pre-Exposición (iPrEx) study (multiple countries, 2007-2010) of preexposure prophylaxis for human immunodeficiency virus, we illustrate how transporting subgroup analyses can produce target-specific subgroup effect estimates and numbers needed to treat. This approach could lead to more tailored and accurate guidance for resource allocation and cost-effectiveness analyses.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  external validity; implementation; number needed to treat; subgroup analyses; target-specific subgroup analyses; transportability

Mesh:

Year:  2021        PMID: 33615327      PMCID: PMC8489435          DOI: 10.1093/aje/kwab045

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  32 in total

Review 1.  "Know your epidemic, know your response": a useful approach, if we get it right.

Authors:  David Wilson; Daniel T Halperin
Journal:  Lancet       Date:  2008-08-05       Impact factor: 79.321

2.  "All Generalizations Are Dangerous, Even This One."-Alexandre Dumas.

Authors:  Laura B Balzer
Journal:  Epidemiology       Date:  2017-07       Impact factor: 4.822

3.  Interpretation of subgroup analyses in randomized trials: heterogeneity versus secondary interventions.

Authors:  Tyler J VanderWeele; Mirjam J Knol
Journal:  Ann Intern Med       Date:  2011-05-17       Impact factor: 25.391

4.  An assessment of clinically useful measures of the consequences of treatment.

Authors:  A Laupacis; D L Sackett; R S Roberts
Journal:  N Engl J Med       Date:  1988-06-30       Impact factor: 91.245

5.  HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.

Authors:  Susan P Buchbinder; David V Glidden; Albert Y Liu; Vanessa McMahan; Juan V Guanira; Kenneth H Mayer; Pedro Goicochea; Robert M Grant
Journal:  Lancet Infect Dis       Date:  2014-03-07       Impact factor: 25.071

6.  Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial.

Authors:  Stephen R Cole; Elizabeth A Stuart
Journal:  Am J Epidemiol       Date:  2010-06-14       Impact factor: 4.897

7.  Composition or Context: Using Transportability to Understand Drivers of Site Differences in a Large-scale Housing Experiment.

Authors:  Kara E Rudolph; Nicole M Schmidt; M Maria Glymour; Rebecca Crowder; Jessica Galin; Jennifer Ahern; Theresa L Osypuk
Journal:  Epidemiology       Date:  2018-03       Impact factor: 4.822

Review 8.  Generalizing Study Results: A Potential Outcomes Perspective.

Authors:  Catherine R Lesko; Ashley L Buchanan; Daniel Westreich; Jessie K Edwards; Michael G Hudgens; Stephen R Cole
Journal:  Epidemiology       Date:  2017-07       Impact factor: 4.822

9.  The Inclusion of Ethnic Minority Patients and the Role of Language in Telehealth Trials for Type 2 Diabetes: A Systematic Review.

Authors:  Talia Isaacs; Daniel Hunt; Danielle Ward; Leila Rooshenas; Louisa Edwards
Journal:  J Med Internet Res       Date:  2016-09-26       Impact factor: 5.428

10.  The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil.

Authors:  Paula M Luz; Benjamin Osher; Beatriz Grinsztejn; Rachel L Maclean; Elena Losina; Madeline E Stern; Claudio J Struchiner; Robert A Parker; Kenneth A Freedberg; Fabio Mesquita; Rochelle P Walensky; Valdilea G Veloso; A David Paltiel
Journal:  J Int AIDS Soc       Date:  2018-03       Impact factor: 5.396

View more
  1 in total

1.  Invited Commentary: Conducting and Emulating Trials to Study Effects of Social Interventions.

Authors:  L Paloma Rojas-Saunero; Jeremy A Labrecque; Sonja A Swanson
Journal:  Am J Epidemiol       Date:  2022-07-23       Impact factor: 5.363

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.